|
JPS5522636A
(en)
|
1978-08-04 |
1980-02-18 |
Takeda Chem Ind Ltd |
Thiazoliding derivative
|
|
WO1985004170A1
(fr)
|
1984-03-21 |
1985-09-26 |
Takeda Chemical Industries, Ltd. |
Derives de thiazolidinedione, leur procede de preparation et compositions medicinales les contenant
|
|
US4582839A
(en)
|
1984-03-21 |
1986-04-15 |
Takeda Chemical Industries, Ltd. |
2,4-thiazolidinediones
|
|
CN1003445B
(zh)
|
1984-10-03 |
1989-03-01 |
武田药品工业株式会社 |
噻唑烷二酮衍生物，其制备方法和用途
|
|
WO1986002073A1
(fr)
|
1984-10-03 |
1986-04-10 |
Takeda Chemical Industries, Ltd. |
Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
|
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
US5167228A
(en)
|
1987-06-26 |
1992-12-01 |
Brigham And Women's Hospital |
Assessment and modification of endogenous circadian phase and amplitude
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5143930A
(en)
|
1990-02-07 |
1992-09-01 |
Sankyo Company, Limited |
Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
|
|
US5356913A
(en)
|
1990-02-09 |
1994-10-18 |
The Upjohn Company |
Use of insulin sensitizing agents to treat hypertension
|
|
EP0579733B1
(en)
|
1991-04-11 |
2001-06-20 |
PHARMACIA & UPJOHN COMPANY |
Thiazolidinedione derivatives, production and use thereof
|
|
US5441971A
(en)
|
1991-04-11 |
1995-08-15 |
The Upjohn Company |
Thiazolidinedione derivatives, production and use thereof
|
|
NO302471B1
(no)
|
1991-12-26 |
1998-03-09 |
Sankyo Co |
Tiazolidinforbindelser og farmasöytisk preparat
|
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
TWI238064B
(en)
*
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
|
IL118778A
(en)
|
1995-07-03 |
1999-07-14 |
Sankyo Co |
Pharmaceutical compositions for the treatment of arteriosclerosis and xanthoma containing an hmg-coa reductase inhibitor
|
|
US7407978B2
(en)
|
1999-04-06 |
2008-08-05 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
|
AU776162B2
(en)
|
1999-04-29 |
2004-08-26 |
City Of Hope |
Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's)
|
|
US6331596B1
(en)
|
1999-06-28 |
2001-12-18 |
Basf Corporation |
Method of preparing carbamate-functional polymers
|
|
WO2001000579A1
(en)
|
1999-06-30 |
2001-01-04 |
Tularik Inc. |
COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY
|
|
AU6118001A
(en)
|
2000-05-03 |
2001-11-12 |
Tularik Inc |
Combination therapeutic compositions and methods of use
|
|
AU2002226365A1
(en)
|
2000-12-01 |
2002-06-11 |
Novartis Ag |
Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
|
|
EE200300519A
(et)
|
2001-04-26 |
2004-02-16 |
L�civa, a.s. |
Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks
|
|
AU2002337749A1
(en)
|
2001-09-28 |
2003-04-07 |
Teva Pharmaceutical Industries Ltd. |
Pioglitazone hydrochloride
|
|
AUPS236902A0
(en)
|
2002-05-16 |
2002-06-13 |
Northern Sydney Area Health Service |
Composition and method for treating hypertension
|
|
AU2003272072A1
(en)
|
2002-07-16 |
2004-02-02 |
Cadila Healthcare Limited |
A process to prepare pioglitazone via several intermediates.
|
|
US20060083784A1
(en)
|
2002-08-07 |
2006-04-20 |
Smithkline Beecham Corporation |
Amorphous pharmaceutical compositions
|
|
US7230016B2
(en)
|
2003-05-13 |
2007-06-12 |
Synthon Ip Inc. |
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
|
|
WO2005021542A2
(en)
|
2003-08-28 |
2005-03-10 |
Ranbaxy Laboratories Limited |
Process for the preparation of pioglitazone
|
|
AR047541A1
(es)
|
2004-02-13 |
2006-01-25 |
Sandoz Ag |
Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
|
|
JP4475983B2
(ja)
|
2004-03-03 |
2010-06-09 |
学校法人日本大学 |
Ｂｍａｌ１を阻害する方法
|
|
AU2005288080B2
(en)
|
2004-09-28 |
2011-10-13 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril compound
|
|
NZ571872A
(en)
|
2006-03-16 |
2011-05-27 |
Metabolic Solutions Dev Co |
Combination therapies of thiazolidinedione analogues and glucocorticoid agonists
|
|
ES2654908T3
(es)
|
2006-03-16 |
2018-02-15 |
Metabolic Solutions Development Company Llc |
Análogos de tiazolidindiona para el tratamiento de enfermedades mediadas por una inflamación metabólica
|
|
CN101454006B
(zh)
|
2006-03-16 |
2012-12-26 |
新陈代谢解决方案开发公司 |
用于治疗高血压以及用于降低血脂的噻唑烷二酮类似物
|
|
US8304441B2
(en)
|
2007-09-14 |
2012-11-06 |
Metabolic Solutions Development Company, Llc |
Thiazolidinedione analogues for the treatment of metabolic diseases
|
|
JP5371988B2
(ja)
|
2007-09-14 |
2013-12-18 |
メタボリック ソリューションズ ディベロップメント カンパニー， エルエルシー |
高血圧を処置するためのチアゾリジンジオン類似体
|
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
|
SI2222272T1
(sl)
|
2008-08-07 |
2013-03-29 |
Pulmagen Therapeutics (Inflammation) Limited |
Zdravljenje respiratorne bolezni.
|
|
WO2010105048A1
(en)
|
2009-03-12 |
2010-09-16 |
Metabolic Solutions Development Company |
Thiazolidinedione analogues
|
|
WO2011017244A1
(en)
|
2009-08-05 |
2011-02-10 |
Metabolic Solutions Development Company |
Polymorphs of 5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)-1,3-thiazolidine-2,4-dione (mitoglitazone)
|
|
KR20120092712A
(ko)
|
2009-12-15 |
2012-08-21 |
메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 |
진성 당뇨병 및 다른 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온 및 복합제
|
|
RU2564661C2
(ru)
|
2009-12-15 |
2015-10-10 |
МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи |
Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ
|
|
JP2013514371A
(ja)
|
2009-12-15 |
2013-04-25 |
メタボリック ソリューションズ ディベロップメント カンパニー， エルエルシー |
肥満および他の代謝性疾患の処置のためのＰＰＡＲγ温存チアゾリジンジオンならびに組み合わせ物
|
|
EP3202401B1
(en)
|
2009-12-15 |
2019-10-23 |
Cirius Therapeutics, Inc. |
Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
|
|
JP2013525362A
(ja)
|
2010-04-21 |
2013-06-20 |
メタボリック ソリューションズ ディベロップメント カンパニー， エルエルシー |
チアゾリジンジオン類似体
|